Specialty drugs represent an opportunity to better serve patients, but also pose risks.
The recent rise of custom-made drugs is already redefining the state of regulation, society, and the economy.
In our rearview mirror is a ten-year stretch of experimentation. What looms ahead is the rewriting of healthcare's rules.
Whoever's closest to the consumer will be the gatekeeper of the industry.
Three percent of consumers drive 70 percent of pharmacy spend. Pharmacy is ripe for change.
It's time to get comfortable with being uncomfortable.
How measurement and monitoring will wake physicians up to their dangerous, unnecessary, (and unintentional) prescribing habits.
How to ensure medications work as intended for different patient populations.
There's big buzz around consumer behavior driving outcomes. But clinical data doesn't yet align with behavioral data.
Q&A with the Academy of Nutrition and Dietetics on malnutrition's greatest challenges and opportunities
What if your doctor handed out grocery lists, not a grocery list of pills to take?